250 related articles for article (PubMed ID: 7628302)
1. Metabolism and elimination of 5,6-dimethylxanthenone-4-acetic acid in the isolated perfused rat liver.
Webster LK; Ellis AG; Kestell P; Rewcastle GW
Drug Metab Dispos; 1995 Mar; 23(3):363-8. PubMed ID: 7628302
[TBL] [Abstract][Full Text] [Related]
2. Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver.
Sallustio BC; Fairchild BA; Shanahan K; Evans AM; Nation RL
Drug Metab Dispos; 1996 Sep; 24(9):984-9. PubMed ID: 8886608
[TBL] [Abstract][Full Text] [Related]
3. Disposition and covalent binding of diflunisal and diflunisal acyl glucuronide in the isolated perfused rat liver.
Wang M; Dickinson RG
Drug Metab Dispos; 1998 Feb; 26(2):98-104. PubMed ID: 9456294
[TBL] [Abstract][Full Text] [Related]
4. Disposition of the novel antitumour agent xanthenone-4-acetic acid in the mouse: identification of metabolites and routes of elimination.
Kestell P; Rewcastle GW; Baguley BC
Xenobiotica; 1994 Jul; 24(7):635-47. PubMed ID: 7975728
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
Zhou S; Kestell P; Tingle MD; Paxton JW
Cancer Chemother Pharmacol; 2002 Feb; 49(2):126-32. PubMed ID: 11862426
[TBL] [Abstract][Full Text] [Related]
6. Formation of conjugates of 2-fluoro-beta-alanine and bile acids during the metabolism of 5-fluorouracil and 5-fluoro-2-deoxyuridine in the isolated perfused rat liver.
Sweeny DJ; Barnes S; Diasio RB
Cancer Res; 1988 Apr; 48(8):2010-4. PubMed ID: 2964897
[TBL] [Abstract][Full Text] [Related]
7. Disposition of amphotericin B in the isolated perfused rat liver.
Hong Y; Ramzan I; McLachlan AJ
J Pharm Pharmacol; 2004 Jan; 56(1):35-41. PubMed ID: 14979999
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and excretion of 2,6-dinitro [14C]toluene in vivo and in isolated perfused rat livers.
Long RM; Rickert DE
Drug Metab Dispos; 1982; 10(5):455-8. PubMed ID: 6128192
[TBL] [Abstract][Full Text] [Related]
9. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
10. The disposition of an antileishmanial 8-aminoquinoline drug in the isolated perfused rat liver: thermospray liquid chromatography-mass spectrometry identification of metabolites.
Shipley LA; Coleman MD; Brewer TG; Ashmore RW; Theoharides AD
Xenobiotica; 1990 Jan; 20(1):31-44. PubMed ID: 2327106
[TBL] [Abstract][Full Text] [Related]
11. Hepatic metabolism of 7,12-dimethylbenz(a)anthracene in male, female, and ovariectomized Sprague-Dawley rats.
Vater ST; Baldwin DM; Warshawsky D
Cancer Res; 1991 Jan; 51(2):492-8. PubMed ID: 1898712
[TBL] [Abstract][Full Text] [Related]
12. Competing pathways in drug metabolism. I. Effect of input concentration on the conjugation of gentisamide in the once-through in situ perfused rat liver preparation.
Morris ME; Yuen V; Tang BK; Pang KS
J Pharmacol Exp Ther; 1988 May; 245(2):614-24. PubMed ID: 3367309
[TBL] [Abstract][Full Text] [Related]
13. Hepatic disposition of the acyl glucuronide1-O-gemfibrozil-beta-D-glucuronide: effects of dibromosulfophthalein on membrane transport and aglycone formation.
Sabordo L; Sallustio BC; Evans AM; Nation RL
J Pharmacol Exp Ther; 1999 Feb; 288(2):414-20. PubMed ID: 9918540
[TBL] [Abstract][Full Text] [Related]
14. Hepatic disposition of the acyl glucuronide 1-O-gemfibrozil-beta-D-glucuronide: effects of clofibric acid, acetaminophen, and acetaminophen glucuronide.
Sabordo L; Sallustio BC; Evans AM; Nation RL
J Pharmacol Exp Ther; 2000 Oct; 295(1):44-50. PubMed ID: 10991959
[TBL] [Abstract][Full Text] [Related]
15. Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid.
Zhou S; Paxton JW; Tingle MD; Kestell P
Drug Metab Dispos; 2000 Dec; 28(12):1449-56. PubMed ID: 11095582
[TBL] [Abstract][Full Text] [Related]
16. Preclinical prediction of factors influencing the elimination of 5,6-dimethylxanthenone-4-acetic acid, a new anticancer drug.
Miners JO; Valente L; Lillywhite KJ; Mackenzie PI; Burchell B; Baguley BC; Kestell P
Cancer Res; 1997 Jan; 57(2):284-9. PubMed ID: 9000569
[TBL] [Abstract][Full Text] [Related]
17. Glucuronidation as a transient intermediate metabolic step in the elimination of (-)-carbovir. Identification of (-)-carbovir-5'-O-glucuronide in rat bile.
Zimmerman CL; Iyer KR; Faudskar AL; Remmel RP
Drug Metab Dispos; 1993; 21(5):902-10. PubMed ID: 7902254
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of the anticancer drug flavopiridol, a new inhibitor of cyclin dependent kinases, in rat liver.
Jäger W; Zembsch B; Wolschann P; Pittenauer E; Senderowicz AM; Sausville EA; Sedlacek HH; Graf J; Thalhammer T
Life Sci; 1998; 62(20):1861-73. PubMed ID: 9600328
[TBL] [Abstract][Full Text] [Related]
19. Identification of new flavone-8-acetic acid metabolites using mouse microsomes and comparison with human microsomes.
Pham MH; Auzeil N; Regazzetti A; Dauzonne D; Dugay A; Menet MC; Scherman D; Chabot GG
Drug Metab Dispos; 2007 Nov; 35(11):2023-34. PubMed ID: 17664249
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroid metabolism in isolated perfused rat liver and kidney. Experimental studies with emphasis on aldosterone.
Egfjord M
Acta Physiol Scand Suppl; 1995; 627():1-42. PubMed ID: 8848946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
